首页> 外文期刊>Frontiers in Cell and Developmental Biology >Novel Cell Culture Paradigm Prolongs Mouse Corneal Epithelial Cell Proliferative Activity in vitro and in vivo
【24h】

Novel Cell Culture Paradigm Prolongs Mouse Corneal Epithelial Cell Proliferative Activity in vitro and in vivo

机译:小细胞培养范式在体外和体内延长小鼠角膜上皮细胞增殖活性

获取原文
           

摘要

It has been a long-standing challenge to obtain from cell cultures adequate amounts of mouse corneal epithelial cells (mCEC) to perform transplantation surgery. This limitation is attributable to the passage dependent declines in their proliferative activity. We describe here development of a novel 6C medium that contains six different modulators of different signaling pathways, which control proliferative mCEC activity. Its usage shortens the time and effort required to obtain epithelial sheets for hastening healing of an epithelial wound in an experimental animal model. This serum-free 6C medium contains:Y27632, forskolin, SB431542, DAPT, IWP-2, LDN-193189 and also DermaLife K keratinocyte calcium. Their inclusion inhibits rises in four specific markers of epithelial mesenchymal transdifferentiation:ZEB1/2, Snail, β-catenin and α-SMA. This medium is applied in a feeder-free air-lifted system to obtain sufficient populations of epithelial progenitor cells whose procurement is facilitated due to suppression of progenitor epithelial cell transdifferentiation into epithelial-mesenchymal cells. Diminution of this decline in transdifferentiation was confirmed based on the invariance of P63, K14, Pax6 and K12 gene expression levels. This cell culture technique is expected to facilitate ex vivo characterization of mechanisms underlying cell fate determination. Furthermore, its implementation will improve yields of progenitor mouse corneal epithelial cells, which increases the likelihood of using these cells as a source to generate epithelial sheets for performing transplantation surgery to treat limbal stem cell deficiency in a clinical setting. In addition, the novel insight obtainable from such studies is expected to improve the outcomes of corneal regenerative medicine.
机译:从细胞培养物中获得足够量的小鼠角膜上皮细胞(MCEC)是一种长期存在的挑战,以进行移植手术。这种限制可归因于其增殖活动中的依赖性下降。我们在这里描述了一种新的6C培养基,其包含六种不同信号途径的不同调节剂,其控制增殖性MCEC活动。它的用途缩短了获得在实验动物模型中加速上皮伤口的加速愈合的上皮片所需的时间和精力。这种无血清6C培养基包含:Y27632,Forskolin,SB431542,DAPT,IWP-2,LDN-193189以及Dermalife K角质形成细胞钙。它们的包容性抑制在上皮间充质转换的四种特异性标记中升高:Zeb1 / 2,蜗牛,β-连环蛋白和α-SMA。该培养基应用于无饲养的空气提升系统,以获得足够的上皮祖细胞群,由于抑制祖先的上皮细胞转化为上皮 - 间充质细胞,因此促进了采购的采购。基于P63,K14,PAX6和K12基因表达水平的不变性,确认了转移转化强度下降的减少。预计该细胞培养技术将促进潜在的细胞命运决定的机制的exvivo表征。此外,其实施将提高祖先小鼠角膜上皮细胞的产量,这增加了使用这些细胞作为产生用于进行移植手术的上皮片的源来治疗临床环境中的突然干细胞缺乏的可能性。此外,预计可以从这些研究中获得的新颖洞察力改善角膜再生医学的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号